Get started
PHARMING GROUPPHARMING GROUPPHARMING GROUP

PHARMING GROUP

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

PHARM trade ideas

Rising triangle in anticipation of accelerated approval of FDAPharming has received acceptance from both the EMA and FDA for the accelerated review of leniolisib. The new drug is anticipated to generate significantly more revenue compared to its current profitable drug Ruconest. While the company has been profitable for the past years, it needed to find new sources of income to be able to grow the value of the company. The end of 23Q1 will be crucial for shareholders, who would love to see acceptance from both EMA and FDA. Targets of 3-5 euro per share are not out of the question. A big spike can be expected, as a lot of people are expected to jump on this ship in case of approval. Based on the rising triangle pattern that has been forming since June 22, the theoretical price target would be 1.90 euro, with a breakout before March 8. For now we would look at reaching prior highs. Target 1: 1.50 euro Target 2: 1.635 euro Target 3: 1.90 euro
EURONEXT:PHARMLong
by Ntooj
Fading into PHARM negative trend.Pharming Group - 30d expiry- We look to Sell a break of 0.934 (stop at 0.993) Short term bias has turned negative. Daily signals are mildly bearish. A higher correction is expected. We are trading at overbought extremes. 0.936 has been pivotal. A break of 0.936 is needed to confirm follow through negative momentum. There is no clear indication that the downward move is coming to an end. Our profit targets will be 0.794 and 0.754 Resistance: 0.980 / 1.054 / 1.110 Support: 0.936 / 0.900 / 0.860 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis , like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis , as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
EURONEXT:PHARMShort
by Saxo
PHARMING LONG after touched 200EMAPharming is a company with good fundamentals and now also available on the NASDAQ via a ADR (10 stocks). Take a look to the company. Technical Analyse: After it touched the 200 EMA you can see the big push to the North. My expectation is that this stock will go further North up, probably at least to it's last resistance at 1,46€. I will keep it simple, because this picture on the daily chart is pretty powerfull and if you really want to take a shot with this company, look into the fundamentals also. Personally i do have stocks of this company for a while now. For me this is a buy and hold stock. No dividends, but lots of potential amd already making profits.
EURONEXT:PHARMLong
by JohanRD
6
PHARMING LONG termHello all, Here another TA of me, this time on the stock PHARMING. Its a very interesting company, i would advice you to dive in the fundamentals for further information. I will just show the possibilities with TA. Before you choose to buy and hold a stock, always do your homework on the fundamentals. TA can help you by choosing a good moment and price to buy the stock. PHARMING is fundamental a healthy company and one of a kind. If you are interested in a possible gem, please check out the fundamentals and see it for yourself. From TA perspective, price is moving into a triangle/flag pattern and 'soon' have to choose direction. Personaly I'm thinking it can go both ways. But with stocks, and specialy the ones you want to hold for long term, you just have to check out the fundamentals. I do not recommend this stock for daytrading, although there are possibilities. As you can see the jump earlier after the news of 5 people who have bin treated with their medicine, RUCONEST, pure doing analysis on the chart on this stock is a bit hard and tricky in my opinion. You just never know when there will be published some news what will effect the price big time. Personally i do think the current price can be a good moment to start buying this stock for the LONG term. Buy and Hold. This is just my view and opinion and in the end you always decide for yourself . Don't ever go blind on someone else his vision, create one for your self! Have fun and good luck trading. :)
EURONEXT:PHARMLong
by JohanRD
1
Pharming Group possible break of major resistance at 1.61Pharming group holdings has been hold back twice in history at around 1.6, i have been watching the MAC D and Stochastic indicator on the daily, they both show interesting signals such as on the macd: Descending red with ascending green, this would at least tell me a new attempt of breaking 1.61 is within a week. Stochastic on the daily is getting a positive slope on the daily and as shown i drawed a current support/ resistance line wich it will possibly bounce off of. Keeping this in mind i think Pharming group seems like a good invest for the coming year, if ofcourse we can get above 1.61 GOODLUCK!
EURONEXT:PHARMLong
by IMakeProfit
Penny stocks: Pharming (3/5) Education + Spread your investmentsRisk: Low Please be advised that this is only an idea, so you are responsible for any losses yourself. Dear followers, First of all, many thanks for following and liking my ideas. As promised I provide you with some penny stocks today, but for the most part I keep focusing on the crypto analyses. Education: Do you know people who had to leave their home because they could no longer pay their mortgage after losing a job? I do. No matter how bad it is for them, these people have made a mistake at an earlier stage. Probably out of ignorance. Did you hear the stories about people who lost their money in the stock market in 2002 and went to drugs? I do. What if the crypto market crashes? Have you lost all your money? Then you have made exactly the same mistake. The trick is to create multiple cash flows. A job, maybe two or trhee jobs, cryptos, currencies, interest, stocks, dividends, et cetera. When one or two cash flows are lost, you can still continue to live in your house. Otherwise you have still made a mistake by buying an overpriced house that you actually could not afford. This is why I provide you today with 5 penny stocks that are technically right, about to break out and have a great profit potential for the coming years. Imagine one of these companies is a sleeping giant? Two shares rise a little, one falls and one company goes bankrupt? By spreading your investments you still have the jackpot and you have perhaps made a 1000% return or more! Stock The third penny stock is one of my favorites, Pharming Group. I already made a lot of money with this stock, because I'm in since 0.20 and I just increased my position. Pharming Group N.V. is committed to the development of innovative products for the treatment of unmet medical needs. It focusses on the development and production of human therapeutic proteins to provide life-changing solutions to patients. Pharming is ready to break out. Fundamentally, their turnover increases exponentially! If we close with a candle above the blue trendline a breakout is confirmed. (Click the play button on the chart to look for confirmation) Our first target will be €1,80 but I've this stock in my long-term portfolio. I put the risk on low, because I did a lot of research to this company and I know their products and numbers very well. Buy: Now or if it breaks out. Please, follow and like for more trading ideas. Questions? Feel free to ask and your feedback is welcome!
EURONEXT:PHARMLong
by Trades999
27